Lozana 200 mg Tablet is a potent gonadotropin inhibitor used in the management of several hormone-dependent and gynecological conditions. It is primarily indicated for endometriosis, benign breast disease, menorrhagia, gynecomastia, and for preoperative thinning of the endometrium before hysteroscopic endometrial ablation. By suppressing ovarian hormone production and modulating the pituitary-ovarian axis, Lozana 200 mg effectively reduces estrogenic stimulation in target tissues, alleviating symptoms and promoting regression of pathological tissue changes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Drugs Affecting (Inhibiting) Gonadotrophin

Indications

Lozana 200 mg is indicated for:

• Endometriosis: Reduces ectopic and normal endometrial tissue activity, leading to atrophy and relief from pain and associated symptoms

• Benign breast disease: Alleviates nodularity, tenderness, and pain possibly by decreasing ovarian estrogen production

• Menorrhagia: Helps control excessive menstrual bleeding

• Gynecomastia: Reduces breast tissue enlargement in male adolescents and adults

• Preoperative endometrial thinning: Prepares the endometrium for hysteroscopic procedures

Pharmacology

Lozana 200 mg acts by suppressing the pituitary-ovarian axis, reducing the preovulatory surge of FSH and LH, and lowering ovarian estrogen production. Additional mechanisms include:

• Direct inhibition of ovarian steroidogenesis

• Binding to androgen, progesterone, and glucocorticoid receptors

• Modulating sex-hormone-binding globulin and corticosteroid-binding globulin

• Enhancing metabolic clearance of progesterone

• Reducing immunoglobulin concentrations and autoantibodies in endometriosis

This multifaceted action leads to anovulation, amenorrhea, regression of endometrial tissue, and relief from hormone-dependent symptoms.

Dosage and Administration

Dosage is individualized based on indication and response:

• Endometriosis: 200–800 mg daily in 2 divided doses for 3–6 months (up to 9 months if needed)

• Benign breast disease: 100–400 mg daily in 2 divided doses for 3–6 months

• Menorrhagia: 200 mg once daily; review after 3 months

• Gynecomastia: 200–400 mg daily depending on response, typically 6 months

• Preoperative endometrial thinning: 400–800 mg daily in 2–4 divided doses for 3–6 weeks

Tablets should be taken orally, preferably at the same time each day, and adjusted according to clinical response.

Drug Interactions

• Insulin: May increase insulin resistance; monitor diabetic patients closely

• Estrogens/Progestogens: May interfere with exogenous hormonal therapy; effective non-hormonal contraception is recommended

• Anticonvulsants: Possible changes in carbamazepine, phenytoin, or phenobarbital activity

• Antihypertensives: Potential reduction in effectiveness

• Cyclosporine: May increase plasma concentrations

• Migraine therapy: May reduce efficacy or provoke symptoms

Contraindications

• Pregnancy and breastfeeding (Category X)

• Hepatic, renal, or cardiac impairment

• Porphyria

• Thromboembolic disorders

• Androgen-dependent tumors

• Unexplained vaginal bleeding

• Hypersensitivity to Lozana 200 mg

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include edema, weight gain, sweating, acne, hirsutism, flushing, oily skin or hair, amenorrhea, hepatic dysfunction, CNS or gastrointestinal disturbances, visual changes, reduction in breast size, and elevated liver enzymes.

Precautions and Warnings

Caution is advised in patients with epilepsy, migraine, severe hypertension, diabetes, polycythemia, a history of thrombosis, and in children. Regular monitoring is recommended during therapy.

Overdose

Acute overdose is rare; in case of excessive ingestion, gastric lavage and monitoring are recommended. Serious reactions are unlikely from a single dose.

Storage

Store at 15–30°C in a dry place, protected from light. Keep out of reach of children.